Ares Capital's second quarter looked very different on two ledgers that management itself separates. The GAAP net income line collapsed to $171 million ($0.24 a share) - about half the year-ago print - because a $183 million mark-to-market loss on the existing portfolio overwhelmed an otherwise steady operating quarter. The Core EPS line, the company's own non-GAAP measure of recurring earnings, held at $0.47 a share, only $0.03 below a year ago. Net investment income actually grew 5% to $359 million on a 3% rise in total investment income to $768 million; expense discipline and a one-time $21 million reversal of the capital-gains incentive-fee accrual kept the operating engine in line. The quarter is the cleanest illustration of the BDC investing model: the operating yield-driven book earns roughly a dollar a share on a Core basis every six months, and the GAAP print fluctuates around it with the mark. The freshest fact was that 60 basis points of the year-over-year mark were concentrated in a higher non-accrual ratio (2.4% of the portfolio at amortized cost, up from 1.8%) and a step-down in the fair value of the equity investment in the IHAM asset-management subsidiary.
The balance sheet moved in the right direction. Management raised approximately $1.2 billion of incremental debt capacity in the quarter, including the upsize and extension of the senior secured revolver (now about $5.5 billion in commitments with a May 2030/2031 maturity on the extending lenders) and a $1.5 billion upsize of the consolidated BNP facility. In June the company also launched the first commercial paper program in the BDC sector - a $1.0 billion ceiling backed by the revolver - establishing a lower-cost funding channel alongside the existing unsecured-note ladder. Cash stood at $383 million, total principal debt at $15.9 billion, and the company entered the third quarter with approximately $6.0 billion of available liquidity after repaying the $1.0 billion 2.150% July 2026 notes at maturity. The debt-to-equity ratio was 1.15x (1.12x net of available cash), and the asset coverage ratio stood at 186% versus the 150% statutory minimum - wide cushion against a stressed credit environment.
The price action was not kind. After trading around $22.70 in mid-July, ARCC closed the day of the release at $18.71, fell to $17.40 by August 5 - the 52-week low - and recovered modestly to $20.10 at the most recent close. At that price the stock trades at roughly 1.04x net asset value ($19.35 NAV per share, 718 million shares = $13.89 billion of book equity) and offers a 9.6% dividend yield on the $0.48 quarterly run-rate. The yield sits at the low end of the BDC peer set; the valuation premium to NAV is roughly 4%, dwarfed by specialty-lender MAIN (~1.8x P/NAV, ~2.8% yield) and Hercules Capital (~1.5x P/NAV, ~11% yield). The thesis from here is whether the $0.59 NAV per share decline in the first half (from $19.94 at year-end to $19.35 at June 30, a 3.0% book decline) - driven by the $494 million in net realized and unrealized losses that accrued mostly in Q1 - is the floor or another leg. The Q3 dividend is held at $0.48; the run-rate dividend coverage on Core EPS is roughly 0.97x (Core $0.47 / $0.48 declared), thin but consistent with how the BDC model converts book yield into distributable cash over a full year.